THE EFFECT OF CRP/LYMPHOCYTE AND NEUTROPHIL/LYMPHOCYTE RATIOS ON LENGTH OF HOSPITAL STAY AND MORTALITY IN PATIENTS ADMITTED TO THE BURN UNIT
Condition(s) studied
Investigational drug(s) / intervention(s)
Routine blood samples collected for CRP, neutrophil, and lymphocyte counts during ICU admission.: Routinely checked complete blood count and biochemistry tests
Study summary
This retrospective study aims to evaluate the prognostic value of systemic inflammatory markers, specifically the C-reactive protein-to-lymphocyte ratio (CLR) and neutrophil-to-lymphocyte ratio (NLR), in patients admitted to the burn intensive care unit. Burn injury triggers a profound systemic inflammatory response, which significantly influences clinical outcomes. By analyzing medical records, the study investigates whether admission or dynamic changes in CLR and NLR correlate with the length of hospital stay (LOS) and in-hospital mortality. The ultimate goal is to identify cost-effective, readily available biomarkers for early risk stratification in severe burn management.
Eligibility
Primary outcome measure(s)
- In-Hospital Mortality — 01.01.2020 - 31.12.2025
Evaluation of the association between baseline CRP/lymphocyte ratio (CLR) and neutrophil/lymphocyte ratio (NLR) values upon admission and the occurrence of all-cause in-hospital mortality.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Samsun Universitesi | Samsun | Atakum |
More Samsun University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07855432 on ClinicalTrials.gov ↗ ← All trials in Turkey